These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22763653)

  • 1. Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N670S TSH receptor germline mutation masquerading as TSH receptor antibody negative Graves' disease.
    Schaarschmidt J; Paschke S; Özerden M; Jäschke H; Huth S; Eszlinger M; Meller J; Paschke R
    Horm Metab Res; 2012 Dec; 44(13):962-5. PubMed ID: 22763653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.
    Gozu HI; Lublinghoff J; Bircan R; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):125-34. PubMed ID: 20138963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy.
    Patel KA; Knight B; Aziz A; Babiker T; Tamar A; Findlay J; Cox S; Dimitropoulos I; Tysoe C; Panicker V; Vaidya B
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):328-333. PubMed ID: 30372544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
    Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
    Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM; Aliesky HA; Rapoport B
    Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.
    Nishihara E; Chen CR; Higashiyama T; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
    Thyroid; 2010 Nov; 20(11):1307-14. PubMed ID: 20929407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders caused by mutations of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 1998 Jul; 56(7):1856-60. PubMed ID: 9702065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
    Führer D; Wonerow P; Willgerodt H; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of thyrotropin receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-thyrotropin receptor antibodies.
    Nishihara E; Fukata S; Hishinuma A; Amino N; Miyauchi A
    Thyroid; 2014 May; 24(5):789-95. PubMed ID: 24279482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
    Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease.
    Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):516-21. PubMed ID: 16235153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
    Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
    Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.
    Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A
    J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
    Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
    Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the TSH receptor as cause of congenital hyperthyroidism.
    Schwab KO; Söhlemann P; Gerlich M; Broecker M; Petrykowski W; Holzapfel HP; Paschke R; Grüters A; Derwahl M
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():124-8. PubMed ID: 8981019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A family with a novel TSH receptor activating germline mutation (p.Ala485Val).
    Akcurin S; Turkkahraman D; Tysoe C; Ellard S; De Leener A; Vassart G; Costagliola S
    Eur J Pediatr; 2008 Nov; 167(11):1231-7. PubMed ID: 18175146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.